Á lódáil...
Emerging Immunotherapy for Acute Myeloid Leukemia
Several immune checkpoint molecules and immune targets in leukemic cells have been investigated. Recent studies have suggested the potential clinical benefits of immuno-oncology (IO) therapy against acute myeloid leukemia (AML), especially targeting CD33, CD123, and CLL-1, as well as immune checkpoi...
Na minha lista:
| Foilsithe in: | Int J Mol Sci |
|---|---|
| Main Authors: | , , , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
MDPI
2021
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7920435/ https://ncbi.nlm.nih.gov/pubmed/33669431 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms22041944 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|